XT
MDGL icon

XTX Topco’s Madrigal Pharmaceuticals MDGL Stock Holding History

XTX Topco’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
5,738
+3,080
+116% +$1.58M 0.04% 723
2026
Q1 		$1.39M Sell
2,658
-161
-6% -$76.9K 0.02% 1150
2025
Q4 		$1.64M Buy
+2,819
New +$1.44M 0.04% 695
2025
Q3 		– Sell
-1,238
Closed -$375K – 2986
2025
Q2 		$375K Buy
1,238
+54
+5% +$16.1K 0.02% 1292
2025
Q1 		$392K Buy
+1,184
New +$389K 0.02% 1207
2024
Q4 		– Sell
-4,881
Closed -$1.04M – 2683
2024
Q3 		$1.04M Buy
+4,881
New +$1.25M 0.07% 412
2024
Q2 		– Sell
-1,980
Closed -$529K – 2222
2024
Q1 		$529K Buy
1,980
+988
+100% +$233K 0.07% 454
2023
Q4 		$230K Buy
+992
New +$174K 0.05% 850
2023
Q1 		– Sell
-1,222
Closed -$355K – 1512
2022
Q4 		$355K Buy
+1,222
New +$120K 0.08% 479

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's MDGL Position: Q2 2026 in Review

XTX Topco increased its Madrigal Pharmaceuticals (MDGL) stake by 116% in Q2 2026, buying an estimated $1.58M and bringing the position to 5,738 shares worth $3.08M. The position accounts for 0.04% of the portfolio, ranked #723.

XTX Topco first reported a position in MDGL in Q4 2022 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • XTX Topco held 5,738 shares of Madrigal Pharmaceuticals worth $3.08M as of Q2 2026.
  • XTX Topco bought 3,080 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.58M.
  • Madrigal Pharmaceuticals made up 0.04% of XTX Topco's portfolio in Q2 2026, its #723 holding.
  • XTX Topco first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.